Biomedical functions and applications of nanomaterials in tumor diagnosis and treatment: perspectives from ophthalmic oncology Dr. Kamal Kant Kohli2 Jan 2026 8:45 PM ISTEye tumors are difficult to treat because drugs often struggle to reach tumor tissue without damaging healthy structures of the eye. A new review...
FDA Approves Breakthrough EDOF Contact Lens for Presbyopia Dr. Kamal Kant Kohli31 Dec 2025 8:00 PM ISTThe US. Food and Drug Administration (FDA) has officially cleared Deseyne contact lenses, developed by Bruno Vision Care, for the correction of...
Machine Learning Enables Personalized Prediction of Glaucoma Progression, Suggests Research Medha Baranwal28 Dec 2025 8:15 PM ISTRussian Federation: Researchers applied machine learning models to predict glaucoma progression using a wide range of biomarkers, including...
High-Dose Aflibercept Effective With Extended Dosing in Polypoidal Choroidal Vasculopathy: PULSAR Analysis Medha Baranwal26 Dec 2025 8:00 PM ISTSouth Korea: In a post hoc analysis of the randomized PULSAR trial, aflibercept 8 mg demonstrated noninferior visual outcomes compared with the...
Dietary Nitrate Intake from Leafy Green Vegetables Tied to Reduced Glaucoma Risk: Study Medha Baranwal25 Dec 2025 8:30 PM ISTJapan: Cross-sectional and prospective studies suggest that dietary nitrate, particularly from leafy green vegetables, may have a protective effect...
SGLT-2 Inhibitors Have Neutral Impact on Incidence of Diabetic Retinopathy Risk: Study Finds Medha Baranwal23 Dec 2025 11:15 AM ISTSpain: Researchers have found in a new study that sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a neutral effect on the incidence of...
Alembic Pharma secures USFDA approval for Glaucoma treatment Ruchika Sharma18 Dec 2025 12:34 PM ISTVadodara: Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New...
Tirzepatide Linked to Lower Glaucoma Risk in Type 2 Diabetes Compared to Other Weight Loss Drugs: Study Medha Baranwal17 Dec 2025 8:45 PM ISTUSA: A large retrospective cohort study found that the dual GIP/GLP-1 receptor agonist tirzepatide was associated with a significantly reduced risk of...
Lupin receives positive EMA comittee opinion for eye therapy Ranluspec Ruchika Sharma17 Dec 2025 12:58 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
GLP-1 Drugs Linked to Lower Cataract and Dry AMD Risk: Study Dr Riya Dave15 Dec 2025 9:00 PM ISTRecent studies show that GLP-1 receptor agonists are associated with a significantly reduced risk of age-related cataracts and a lower risk of...
Study links genetic variants to risk of blinding eye disease in premature infants Dr. Kamal Kant Kohli14 Dec 2025 8:30 PM ISTA new study from the University of Oklahoma suggests that small genetic differences in two proteins-previously known for their role in premature...
Biocon Biologics signs settlement, license agreement to commercialize biosimilar Aflibercept worldwide Ruchika Sharma14 Dec 2025 4:30 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced a new settlement...
